PEJMF (Peijia Medical) Operating Income: $-27.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PEJMF Peijia Medical Ltd PEJMF
74 GF Score
Price $1.39
GF Value $2.78
! 4 Warning Signs
View Full Analysis

What is Peijia Medical Operating Income?

Peijia Medical PEJMF 74 Operating Income is $-27.6 Mil as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 74/100 and a GF Value™ of $2.78. The stock has 4 warning signs investors should review.

Peijia Medical's Operating Income for the six months ended in Dec. 2025 was $-18.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-27.6 Mil.

Warning Sign:

Peijia Medical Ltd has never been profitable in the past 3 years. It lost money every year.

Operating Margin % is calculated as Operating Income divided by its Revenue. Peijia Medical's Operating Income for the six months ended in Dec. 2025 was $-18.4 Mil. Peijia Medical's Revenue for the six months ended in Dec. 2025 was $51.0 Mil. Therefore, Peijia Medical's Operating Margin % for the quarter that ended in Dec. 2025 was -35.99%.

Good Sign:

Peijia Medical Ltd operating margin is expanding. Margin expansion is usually a good sign.

Peijia Medical's 5-Year average Growth Rate for Operating Margin % was 48.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Peijia Medical's annualized ROC % for the quarter that ended in Dec. 2025 was -12.35%. Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -35.19%.


Peijia Medical  (OTCPK:PEJMF) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Peijia Medical's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-36.738 * ( 1 - 0% )/( (278.642 + 316.382)/ 2 )
=-36.738/297.512
=-12.35 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Peijia Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-36.246/( ( (103.987 + max(-1.416, 0)) + (102.007 + max(-1.967, 0)) )/ 2 )
=-36.246/( ( 103.987 + 102.007 )/ 2 )
=-36.246/102.997
=-35.19 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.175 + 19.077 + 4.182) - (32.85 + 0 + 0)
=-1.416

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.558 + 20.716 + 11.278) - (40.519 + 0 + 1.4210854715202E-14)
=-1.967

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Peijia Medical's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-18.369/51.041
=-35.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Peijia Medical Operating Income Related Terms


Peijia Medical Operating Income Historical Data

* Premium members only.

The historical data trend for Peijia Medical's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peijia Medical Operating Income Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial -86.29 -79.14 -58.24 -31.63 -27.73

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.93 -11.84 -19.84 -9.18 -18.37
PEJMF
74GF Score
Peijia Medical Ltd PEJMF
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peijia Medical Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-27.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of $-27.6 Mil mean?
Peijia Medical (PEJMF) has a Operating Income of $-27.6 Mil as of Dec. 2025. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Peijia Medical and its competitors.
Is Peijia Medical's Operating Income too high?
Peijia Medical's current Operating Income is $-27.6 Mil. Overall, Peijia Medical has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's Operating Income compare to ABT and SYK?
Peijia Medical's Operating Income of $-27.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Medical Devices & Instruments company?
A good Operating Income depends on the Medical Devices & Instruments industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Peijia Medical and its competitors. Peijia Medical's current Operating Income is $-27.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current Operating Income of $-27.6 Mil. The stock's GF Value™ is $2.78, compared to a current price of $1.39 — trading 50.1% below its estimated fair value. The current Operating Income is $-27.6 Mil. Peijia Medical's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current Operating Income is $-27.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peijia Medical (PEJMF) Overvalued in 2026?

Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued. The current stock price of $1.39 is trading 50.1% below its estimated GF Value™ of $2.78.

Key valuation signals for PEJMF:

  • Operating Income: $-27.6 Mil
  • GF Value™: $2.78 vs. price of $1.39 (50.1% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Peijia Medical Business Description

Other Exchanges 09996:Hong Kong4WO:Germany
Address No.18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
74GF Score

Get the complete analysis for PEJMF

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$2.78
GF Value